RenovoRx, Inc. (RNXT) Form 8-K Material Events
RenovoRx, Inc. (RNXT) is a publicly traded company on the Nasdaq, categorized under SIC 3841 (Surgical & Medical Instruments & Apparatus). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: RNXT
CIK: 1574094
Exchange: Nasdaq
SIC 3841: Surgical & Medical Instruments & Apparatus
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Frank, Rimerman & Co. LLP
Auditor SinceSince 12/31/2024 12:00:00 AM
Lead Engagement PartnerBryan Gendron
Audit LocationSan Francisco, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| RW | 2026-10-16 | — | RW | 0001493152-26-047333 | View SEC Doc Filr Page |
| 4 | 2026-10-02 | 2026-10-01 | 4 | 0001493152-26-045582 | View SEC Doc Filr Page |
| 4 | 2026-10-02 | 2026-10-01 | 4 | 0001493152-26-045580 | View SEC Doc Filr Page |
| 4 | 2026-10-02 | 2026-10-01 | 4 | 0001493152-26-045578 | View SEC Doc Filr Page |
| 4 | 2026-10-02 | 2026-10-01 | 4 | 0001493152-26-045577 | View SEC Doc Filr Page |
| 4 | 2026-09-15 | 2026-09-10 | 4 | 0001493152-26-042650 | View SEC Doc Filr Page |
| 8-K | 2026-08-20 | 2026-08-20 | 8-K | 0001493152-26-039472 | View SEC Doc Filr Page |
| 10-Q | 2026-08-13 | 2026-06-30 | 10-Q | 0001193125-26-349190 | View SEC Doc Filr Page |
| 8-K/A | 2026-08-13 | 2026-08-12 | 8-K/A | 0001193125-26-349157 | View SEC Doc Filr Page |
| 8-K | 2026-08-12 | 2026-08-12 | 8-K | 0001193125-26-346894 | View SEC Doc Filr Page |
| 8-K | 2026-08-04 | 2026-08-04 | 8-K | 0001493152-26-035995 | View SEC Doc Filr Page |
| 8-K | 2026-07-02 | 2026-07-01 | 8-K | 0001493152-26-031662 | View SEC Doc Filr Page |
| S-8 | 2026-06-30 | — | S-8 | 0001493152-26-031320 | View SEC Doc Filr Page |
| 8-K | 2026-06-30 | 2026-06-30 | 8-K | 0001493152-26-031303 | View SEC Doc Filr Page |
| 4 | 2026-06-24 | 2022-03-03 | 4 | 0001493152-26-029958 | View SEC Doc Filr Page |
| 4 | 2026-05-21 | 2026-05-19 | 4 | 0001493152-26-024726 | View SEC Doc Filr Page |
| 10-K/A | 2026-05-15 | 2025-12-31 | 10-K/A | 0001193125-26-227256 | View SEC Doc Filr Page |
| 10-Q | 2026-05-14 | 2026-03-31 | 10-Q | 0001193125-26-224100 | View SEC Doc Filr Page |
| 8-K | 2026-05-14 | 2026-05-14 | 8-K | 0001193125-26-224080 | View SEC Doc Filr Page |
| DEF 14A | 2026-04-30 | 2026-04-30 | DEF 14A | 0001493152-26-020403 | View SEC Doc Filr Page |
| EFFECT | 2026-04-27 | — | EFFECT Filing | 9999999995-26-001342 | View SEC Doc Filr Page |
| 424B3 | 2026-04-27 | — | 424B3 | 0001493152-26-019183 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-04-27 | — | SCHEDULE 13G/A Filing | 0001493152-26-019065 | View SEC Doc Filr Page |
| CORRESP | 2026-04-23 | — | CORRESP Filing | 0001493152-26-018717 | View SEC Doc Filr Page |
| UPLOAD | 2026-04-22 | — | UPLOAD Filing | 0000000000-26-004102 | View SEC Doc Filr Page |